ParkScreen

A low-cost rapid linkage marker panel for Parkinson's disease

Alessandro De Grandi, Claudia Béu Volpato, Elisa Bedin, Cristian Pattaro, Fabio Marroni, Irene Pichler, Andrew Antony Hicks, Giorgio Casari, Peter Paul Pramstaller

Research output: Contribution to journalArticle

Abstract

A genetic marker screening panel, ParkScreen, optimized for simultaneous marker amplification, was constructed to test or exclude linkage in families with parkinsonism or Parkinson's disease, using only a few affected individuals per family. ParkScreen functionality was proven by detection of linkage to PARK2 in a family with known Parkin mutations, exclusion of linkage to several of the known loci, and detection of suggestive linkage to PARK8, PARK3, and PARK11 in some families. In a novel approach, we also tested the ability of ParkScreen to screen patients originating from isolated populations. Using apparently sporadic patients from geographically isolated Alpine villages, suggestive linkage to PARK11 was found in one village. ParkScreen is a useful and inexpensive tool that allows the rapid screening of patients in families suitable for clinical follow-up and further characterization in order to identify specific mutations or novel genes.

Original languageEnglish
Pages (from-to)235-241
Number of pages7
JournalJournal of Molecular Neuroscience
Volume39
Issue number1-2
DOIs
Publication statusPublished - Sep 2009

Fingerprint

Parkinson Disease
Costs and Cost Analysis
Mutation
Aptitude
Genetic Testing
Parkinsonian Disorders
Genetic Markers
Population
Genes
Parkinson Disease 11

Keywords

  • Indirect genetic diagnosis
  • Linkage studies
  • PD families
  • PD loci
  • Population isolate

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

De Grandi, A., Volpato, C. B., Bedin, E., Pattaro, C., Marroni, F., Pichler, I., ... Pramstaller, P. P. (2009). ParkScreen: A low-cost rapid linkage marker panel for Parkinson's disease. Journal of Molecular Neuroscience, 39(1-2), 235-241. https://doi.org/10.1007/s12031-009-9193-8

ParkScreen : A low-cost rapid linkage marker panel for Parkinson's disease. / De Grandi, Alessandro; Volpato, Claudia Béu; Bedin, Elisa; Pattaro, Cristian; Marroni, Fabio; Pichler, Irene; Hicks, Andrew Antony; Casari, Giorgio; Pramstaller, Peter Paul.

In: Journal of Molecular Neuroscience, Vol. 39, No. 1-2, 09.2009, p. 235-241.

Research output: Contribution to journalArticle

De Grandi, A, Volpato, CB, Bedin, E, Pattaro, C, Marroni, F, Pichler, I, Hicks, AA, Casari, G & Pramstaller, PP 2009, 'ParkScreen: A low-cost rapid linkage marker panel for Parkinson's disease', Journal of Molecular Neuroscience, vol. 39, no. 1-2, pp. 235-241. https://doi.org/10.1007/s12031-009-9193-8
De Grandi A, Volpato CB, Bedin E, Pattaro C, Marroni F, Pichler I et al. ParkScreen: A low-cost rapid linkage marker panel for Parkinson's disease. Journal of Molecular Neuroscience. 2009 Sep;39(1-2):235-241. https://doi.org/10.1007/s12031-009-9193-8
De Grandi, Alessandro ; Volpato, Claudia Béu ; Bedin, Elisa ; Pattaro, Cristian ; Marroni, Fabio ; Pichler, Irene ; Hicks, Andrew Antony ; Casari, Giorgio ; Pramstaller, Peter Paul. / ParkScreen : A low-cost rapid linkage marker panel for Parkinson's disease. In: Journal of Molecular Neuroscience. 2009 ; Vol. 39, No. 1-2. pp. 235-241.
@article{7ed6543f9d2e4d0eaf098eed3863a01b,
title = "ParkScreen: A low-cost rapid linkage marker panel for Parkinson's disease",
abstract = "A genetic marker screening panel, ParkScreen, optimized for simultaneous marker amplification, was constructed to test or exclude linkage in families with parkinsonism or Parkinson's disease, using only a few affected individuals per family. ParkScreen functionality was proven by detection of linkage to PARK2 in a family with known Parkin mutations, exclusion of linkage to several of the known loci, and detection of suggestive linkage to PARK8, PARK3, and PARK11 in some families. In a novel approach, we also tested the ability of ParkScreen to screen patients originating from isolated populations. Using apparently sporadic patients from geographically isolated Alpine villages, suggestive linkage to PARK11 was found in one village. ParkScreen is a useful and inexpensive tool that allows the rapid screening of patients in families suitable for clinical follow-up and further characterization in order to identify specific mutations or novel genes.",
keywords = "Indirect genetic diagnosis, Linkage studies, PD families, PD loci, Population isolate",
author = "{De Grandi}, Alessandro and Volpato, {Claudia B{\'e}u} and Elisa Bedin and Cristian Pattaro and Fabio Marroni and Irene Pichler and Hicks, {Andrew Antony} and Giorgio Casari and Pramstaller, {Peter Paul}",
year = "2009",
month = "9",
doi = "10.1007/s12031-009-9193-8",
language = "English",
volume = "39",
pages = "235--241",
journal = "Journal of Molecular Neuroscience",
issn = "0895-8696",
publisher = "Humana Press",
number = "1-2",

}

TY - JOUR

T1 - ParkScreen

T2 - A low-cost rapid linkage marker panel for Parkinson's disease

AU - De Grandi, Alessandro

AU - Volpato, Claudia Béu

AU - Bedin, Elisa

AU - Pattaro, Cristian

AU - Marroni, Fabio

AU - Pichler, Irene

AU - Hicks, Andrew Antony

AU - Casari, Giorgio

AU - Pramstaller, Peter Paul

PY - 2009/9

Y1 - 2009/9

N2 - A genetic marker screening panel, ParkScreen, optimized for simultaneous marker amplification, was constructed to test or exclude linkage in families with parkinsonism or Parkinson's disease, using only a few affected individuals per family. ParkScreen functionality was proven by detection of linkage to PARK2 in a family with known Parkin mutations, exclusion of linkage to several of the known loci, and detection of suggestive linkage to PARK8, PARK3, and PARK11 in some families. In a novel approach, we also tested the ability of ParkScreen to screen patients originating from isolated populations. Using apparently sporadic patients from geographically isolated Alpine villages, suggestive linkage to PARK11 was found in one village. ParkScreen is a useful and inexpensive tool that allows the rapid screening of patients in families suitable for clinical follow-up and further characterization in order to identify specific mutations or novel genes.

AB - A genetic marker screening panel, ParkScreen, optimized for simultaneous marker amplification, was constructed to test or exclude linkage in families with parkinsonism or Parkinson's disease, using only a few affected individuals per family. ParkScreen functionality was proven by detection of linkage to PARK2 in a family with known Parkin mutations, exclusion of linkage to several of the known loci, and detection of suggestive linkage to PARK8, PARK3, and PARK11 in some families. In a novel approach, we also tested the ability of ParkScreen to screen patients originating from isolated populations. Using apparently sporadic patients from geographically isolated Alpine villages, suggestive linkage to PARK11 was found in one village. ParkScreen is a useful and inexpensive tool that allows the rapid screening of patients in families suitable for clinical follow-up and further characterization in order to identify specific mutations or novel genes.

KW - Indirect genetic diagnosis

KW - Linkage studies

KW - PD families

KW - PD loci

KW - Population isolate

UR - http://www.scopus.com/inward/record.url?scp=74149089620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74149089620&partnerID=8YFLogxK

U2 - 10.1007/s12031-009-9193-8

DO - 10.1007/s12031-009-9193-8

M3 - Article

VL - 39

SP - 235

EP - 241

JO - Journal of Molecular Neuroscience

JF - Journal of Molecular Neuroscience

SN - 0895-8696

IS - 1-2

ER -